Case Report
Copyright ©The Author(s) 2023.
World J Clin Oncol. Dec 24, 2023; 14(12): 620-627
Published online Dec 24, 2023. doi: 10.5306/wjco.v14.i12.620
Table 1 Laboratory findings
Test
Result
Hematology
    WBC6300/μL
    RBC562 × 104/μL
    Hb16.7 g/dL
    Ht49.5%
    Plt23.4 × 104/μL
    PT-INR0.9
    APTT29.0 S
Biochemistry
    Blood sugar92 mg/dL
    CRP0.0 mg/dL
    TP6.8 g/dL
    Alb4.4 g/dL
    T-Bil0.1 mg/dL
    AST19 IU/L
    ALT29 IU/L
    γ-GTP35 IU/L
    ALP363 IU/L
    LDH172 IU/L
    AMY60 IU/L
    BUN23 mg/dL
    Cre0.84 mg/dL
    Na139 mEq/L
    K4.5 mEq/L
    Cl105 mEq/L
Tumor maker
    CEA3.4 ng/mL
    CA19-9< 2.0 ng/dL
    DUPAN-236 U/mL
    Span-1 antigen< 3 U/mL
Alb: Albumin; ALP: Alkaline phosphatase; ALT: Alanine aminotransferase; AMY: Amylase; APTT: Activated partial thromboplastin time; AST: Aspartate aminotransferase; BUN: Blood urea nitrogen; CA19-9: Carbohydrate antigen 19-9; CEA: Carcinogenic antigen; Cre: Creatinine; CRP: C-reactive protein; DUPAN-2: Duke pancreatic mono-clonal antigen type 2; Hb: Hemoglobin; Ht: Hematocrit; LDH: Lactate dehydrogenase; Plt: Platelet; PT-INR: Prothrombin time-international normalized ratio; RBC: Red blood cell count; T-Bil: Total bilirubin; TP: Total protein; WBC: White blood cell count; γ-GTP: Gamma-glutamyl transpeptidase.